Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Biomarker as essential part of clinical development
Biomarker as essential part of clinical development
by lauren
PhUSE 2014 Paper SP06 Renuka Chinthapally, Cytel S...
Precision Medicine Clinical Trial Designs
Precision Medicine Clinical Trial Designs
by luanne-stotts
2018 . AACR Annual Meeting. April 15, 2018 . Edwa...
Hui Yang (Amgen Inc ),
Hui Yang (Amgen Inc ),
by davis
Rui. Tang (Vertex Pharmaceuticals), . Michael . H...
Policy RecommendationsTo provide a pathway for the improvement of acce
Policy RecommendationsTo provide a pathway for the improvement of acce
by anastasia
ValueAwareness,Testing & Educate stakeholders on t...
MicroRNA—a small non-coding RNA: An efficient biomarker for prostate
MicroRNA—a small non-coding RNA: An efficient biomarker for prostate
by LetsGetDrunk
cancer. Khanmi. . Kasomva. ,. Ph.D. . Research . ...
Biomarkers A   biological marker is
Biomarkers A   biological marker is
by madison
a measurable indicator . that . can . tell . us so...
Biomarkers in Phase II designs in cancer clinical trials
Biomarkers in Phase II designs in cancer clinical trials
by conchita-marotz
Methods in Clinical Cancer Research. February 12,...
Breakout Session 4: Personalized Medicine and Subgroup Sele
Breakout Session 4: Personalized Medicine and Subgroup Sele
by trish-goza
Christopher . Jennison. , University of Bath. Rob...
Chee Lee,
Chee Lee,
by olivia-moreira
MBBS (Hons), . MMedSci. (. Clin. . Epid. ), . M...
The new (2021) ELN AML MRD guidelines
The new (2021) ELN AML MRD guidelines
by sylvia
Yishai Ofran 2021. The general idea of MRD measure...
FDA Regulatory Requirements for Successful Biomarker Applications
FDA Regulatory Requirements for Successful Biomarker Applications
by oliver
Early Detection Research Network. September 9, 201...
Evaluation of the Prognostic and Predictive Significance of Hepatocellular
Evaluation of the Prognostic and Predictive Significance of Hepatocellular
by jideborn
Carcinoma Circulating Tumor Cells Expressing Progr...
Personalised Medicine in practice in The Netherlands – a
Personalised Medicine in practice in The Netherlands – a
by calandra-battersby
T. Kievits . Director Vitromics Healthcare Holdin...
Phase II designs in Oncology
Phase II designs in Oncology
by stefany-barnette
Nick . Pavlakis. , MBBS, . MMed. (. Clin. Epi. ...
TOLERANCE:
TOLERANCE:
by kittie-lecroy
Can . We Predict or Induce It? Are Any . Approach...